Endogenous nitric oxide reduces the efficacy of the endothelin system to maintain blood pressure during high epidural anaesthesia in conscious dogs

European Journal of Anaesthesiology

Volumn 24, Issue 8, 2007, Pages 689-696

  Beck, C ^a   Schwarte, L A ^b   Schindler, A W ^c   Scheeren, T W L ^c   Picker, O ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Blood pressure; Dogs; Endothelins; Epidural anaesthesia; Nitric oxide; Vasopressins

Indexed keywords

ENDOTHELIN; ENDOTHELIN RECEPTOR ANTAGONIST; LIDOCAINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; VASOPRESSIN;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; COMPARATIVE STUDY; CONTROLLED STUDY; DOG; DOSE RESPONSE; EPIDURAL ANESTHESIA; FEMALE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RANDOMIZATION; RECEPTOR BLOCKING;

ANESTHESIA, EPIDURAL; ANIMALS; BLOOD PRESSURE; DOGS; ENDOTHELINS; ENZYME INHIBITORS; FEMALE; HORMONE ANTAGONISTS; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PYRIDINES; RANDOM ALLOCATION; RECEPTORS, ENDOTHELIN; RECEPTORS, VASOPRESSIN; TETRAZOLES; VASCULAR RESISTANCE; VASOPRESSINS;

EID: 34447563642     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021507000142     Document Type: Article

References (32)

1. Peters J, Schlaghecke R, Thouet H, Arndt JO. Endogenous vasopressin supports blood pressure and prevents severe hypotension during epidural anesthesia in conscious dogs. Anesthesiology 1990; 73: 694-702.
2. Hopf H-B, Schlaghecke R, Peters J. Sympathetic neural blockade by thoracic epidural anesthesia suppresses renin release in response to arterial hypotension. Anesthesiology 1994; 80: 992-999.
3. Weber C, Schmitt R, Birnboeck H et al. Pharmacokinetics and pharmacodynamics of the endothelin-receptor antagonist bosentan in healthy human subjects. Clin Pharmacol Therapeut 1996; 60: 124-137.
4. Munter K, Ehmke H, Kirchengast H. Maintenance of blood pressure in normotensive dogs by endothelin. Am J Physiol 1999; 45: H1022-H1027.
5. Notarius CF, Erice F, Stewart D, Magder S. Effect of baroreceptor activation and systemic hypotension on plasma endothelin 1 and neuropeptide Y. Can J Physiol Pharmacol 1995; 73: 1136-1143.
6. Cernacek P, Stewart DJ, Levy M. Plasma endothelin-1 response to acute hypotension induced by vasodilating agents. Can J Physiol Pharmacol 1994; 72: 985-991.
7. Picker O, Schindler AW, Scheeren TWL. Endogenous endothelin and vasopressin support blood pressure during epidural anesthesia in conscious dogs. Anesth Analg 2001; 93: 1580-1586.
8. Banting JD, Friberg P, Adams MA. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction. J Hypertension 1996; 14: 975-981.
9. Qiu C, Engels K, Baylis C. Endothelin modulates the pressor actions of acute systemic nitric oxide blockade. J Am Soc Nephrol 1995; 6: 1476-1481.
10. Tagawa T, Imaizumi T, Endo T et al. Vasodilatory effect of arginine vasopressin is mediated by nitric oxide in human forearm vessels. J Clin Invest 1993; 92: 1483-1490.
11. Yamada K, Nakayama M, Nakano H, Mimura N, Yoshida S. Endothelium- dependent vasorelaxation evoked by desmopressin and involvement of nitric oxide in rat aorta. J Physiol 1993; 264: E203-E207.
12. Liard JF. L-NAME antagonizes vasopressin V2-induced vasodilation in dogs. Am J Physiol 1994; 266: H99-H106.
13. Pucci ML, Lin L, Nasjletti A. Pressor and renal vasoconstrictor effects of NG-nitro-L-arginine as affected by blockade of pressor mechanisms mediated by the sympathetic nervous system, angiotensin, prostanoids and vasopressin. J Pharmacol Exp Ther 1992; 261(1): 240-245.
14. Picker O, Wietasch G, Scheeren TW, Arndt JO. Determination of total blood volume by indicator dilution: a comparison of mean transit time and mass conservation principle. Intens Care Med 2001; 27: 767-774.
15. Evans HE, Christensen GC. Millar's Anatomy of the Dog. W.B. Saunders: Philadelphia, 1979.
16. Takamura M, Parent R, Cernacek P, Lavallee M. Influence of dual ET(A)/ET(B)-receptor blockade on coronary responses to treadmill exercise in dogs. J Appl Physiol 2000; 89: 2041-2048.
17. Kruszynski M, Lammek B, Manning M et al. [1-Beta-mercapto-beta, beta-cyclopentamethylenepropionic acid), 2-(O- methyl)tyrosine] argine-vasopressin and [1-betamercapto-beta, beta-cyclopentamethylenepropionic acid)] argine-vasopressine, two highly potent antagonists of the vasopressor response to arginine-vasopressin. J Med Chem 1980; 23: 364-368.
18. Tabrizi-Fard M, Fung H. Pharmacocinetics, plasma protein binding and urinary excretion of N-omega-nitro-L-arginine in rats. Br J Pharmacol 1994; 111: 394-396.
19. Sandgaard NC, Bie P. Natriuretic effect of non-pressor doses of endothelin-1 in conscious dogs. J Physiol (London) 1996; 494: 809-818.
20. Howl J, Wheatley M. Molecular pharmacology of V1a vasopressin receptors. Gen Pharmacol 1995; 26: 1143-1152.
21. Peters J, Kousoulis L, Arndt JO. Effects of segmental thoracic extradural analgesia on sympathetic block in conscious dogs. Br J Anaesth 1989; 63: 470-476.
22. Hogan QH, Stadnicka A, Stekiel TA, Bosnjak ZJ, Kampine JP. Effects of epidural and systemic lidocaine on sympathetic activity and mesenteric circulation in rabbits. Anaesthesiology 1993; 79: 1250-1260.
23. Pollard BJ. Cardiac arrest during spinal anesthesia: common mechanisms and strategies for prevention. Anesth Analg 2002; 92: 252-256.
24. Hasser EM, Bishop VS. Neurogenic and humoral factors maintaining arterial pressure in conscious dogs. Am J Physiol 1988; 255: R693-R698.
25. Thrasher TN, Chen HG, Keil LC. Arterial baroreceptors control plasma vasopressin responses to graded hypotension in conscious dogs. Am J Physiol Regul Integr Comp Physiol 2000; 278: R469-R475.
26. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-142.
27. Hirata Y, Hayakawa H, Kakoki M et al. Receptor subtype for vasopressin-induced release of nitric oxide from rat kidney. Hypertension 1997; 29: 58-64.
28. Hasser EM, Cunningham JT, Sullivan MJ, Curtis KS, Blaine EH, Hay M. Area postrema and sympathetic nervous system effects of vasopressin and angiotensin II. Clin Exp Pharmacol Physiol 2000; 27: 432-436.
29. Boulanger C, Luscher TF. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest 1990; 85: 587-590.
30. Kleinbongard P, Dejam A, Lauer T et al. Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Rad Biol Med 2003; 35: 790-796.
31. Goertz A, Heinrich H, Seeling W. Baroreflex control of heart rate during high thoracic epidural anaesthesia. A randomised clinical trial on anaesthetised humans. Anaesthesia 1992; 47: 984-987.
32. Picker O, Scheeren TW, Arndt JO. Nitric oxide synthases in vagal neurons are crucial for the regulation of heart rate in awake dogs. Basic Res Cardiol 2001; 96: 395-404.